Home > News > Accelrys to Restate Financials
December 22nd, 2005
Accelrys to Restate Financials
Abstract:
Accelrys, Inc. (NASDAQ:ACCL) today announced that upon the recommendation of management, and after consultation with Ernst & Young LLP (E&Y), the Audit Committee determined that the Company will restate its historical financial statements.
Source:
businesswire
Related News Press |
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||